Sorrento Therapeutics, Inc. (SRNE)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 07, 2025

$0.00

P/E Ratio

N/A

Market Cap

$275.64K

Description
Add to research

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento Therapeutics segment consists of developing a portfolio of next generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. The Scilex segment is largely organized around the company's non-opioid pain management operations. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.

Metrics
Add to research

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerSRNE
  • Price$0.0005+25.00%

Trading Information

  • Market cap$0.28M
  • Float98.44%
  • Average Daily Volume (1m)67,763
  • Average Daily Volume (3m)282,515
  • EPS-$1.06

Company

  • Revenue$64.27M
  • Rev growth (1yr)18.78%
  • Net incomeN/A
  • Gross marginN/A
  • EBITDA margin-574.53%
  • EBITDAN/A
  • EVN/A
  • EV/Revenue7.21
  • P/EN/A
  • P/SN/A
  • P/BN/A
  • Debt/EquityN/A
Documents
Add to research